Premium
MASAC Consensus Conference: impediments to conducting clinical research in persons with haemophilia, von Willebrand's disease and rare bleeding disorders
Author(s) -
Koerper M. A.,
Frick N.,
Kessler C. M.
Publication year - 2013
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.12035
Subject(s) - haemophilia , medicine , food and drug administration , von willebrand disease , consensus conference , orphan drug , disease , family medicine , haemophilia b , alternative medicine , advisory committee , pediatrics , haemophilia a , von willebrand factor , pathology , medical emergency , bioinformatics , immunology , political science , public administration , platelet , biology
Summary A consensus conference conducted by the Medical and Scientific Advisory Council of the National Hemophilia Foundation was held in New Orleans, LA , on November 11, 2010, to discuss the impediments to conducting clinical research in persons with haemophilia, von Willebrand's disease and rare bleeding disorders. The conference combined presentations providing academic, non‐profit and industry perspectives with periods of open discussion. The objective of this conference was to identify the many challenges involved in facilitating U.S. Food and Drug Administration approval of innovative products for these patient populations.